CS Paper Radar

Evaluating ADC-only deep learning pipelines for breast cancer detection and segmentation using standalone diffusion-weighted MRI

Pablo García Marcos, Paula Puerta Gonzĺez, Guillermo Lorenzo, Héctor Gómez, Covadonga del Camino, Angel Rio-Alvarez, Víctor M. González

cs.CV cs.AI ·submitted 2026-08-18 12:30 UTC · v1

Abstract

Dynamic contrast-enhanced (DCE) imaging is the gold standard technique for the detection and characterization of breast cancer using magnetic resonance imaging (MRI). However, DCE-MRI requires long acquisition times and the administration of contrast into the bloodstream, which can cause allergic reactions. Alternatively, diffusion-weighted MRI (DW-MRI) is a standard complementary technique for breast MRI that does not require contrast, has shorter acquisition times, and enables calculation of apparent diffusion coefficient (ADC) maps that correlate with tumor cellularity. Yet, despite these technical advantages, deep learning research has focused on DCE-based models and has barely explored the tumor detection performance of DW-MRI and ADC maps either in combination with DCE-MRI or as standalone alternatives. Here, we evaluate the application of different state-of-the-art deep learning techniques for detection and segmentation of breast cancer using ADC-only images. This is, to our knowledge, the first comprehensive evaluation of ADC-only breast cancer pipelines for classification, detection, and segmentation tasks.

Closest papers

Nearest neighbours by meaning across the whole index.

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.70
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

Neoadjuvant chemotherapy response prediction using pretreatment diffusion and contrast-enhanced magnetic resonance imaging with clinical variables

cs.AI cs.CV ·2026-08-18 ·Pablo García Marcos, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez, Covadonga del Camino +4 more
similarity 0.67
Abstract

Prediction of pathological complete response before neoadjuvant chemotherapy may facilitate more tailored therapeutic planning for breast cancer patients. This work proposes a deep-learning model for pretreatment data only, combining apparent diffusion coefficient maps, dynamic contrast-enhanced magnetic resonance imaging, and clinical variables. The study uses the public ACRIN 6698/I-SPY2 multicenter dataset. The architecture employs EfficientNet-B0 pretrained encoders for image feature extraction and late fusion with clinical information. Multiple clinical variables were evaluated, including age, race, histological type, HR/HER2 subtype, SBR grade, and maximum diameter. Only HR/HER2 subtype improved the average area under the receiver operating characteristic curve (AUC) and was retained in the final model. Using stratified five-fold cross-validation, standalone apparent diffusion coefficient maps achieved a mean AUC of 0.79, whereas dynamic contrast-enhanced magnetic resonance imaging achieved 0.74. Adding HR/HER2 subtype improved performance to 0.83 and 0.81, respectively. The final configuration, using both imaging modalities and HR/HER2 subtype, achieved an AUC of 0.86. These results support pretreatment multimodal learning for response prediction, although external validation is required before clinical use.

0.27

DualMiT-Net: Local-Global Transformer-Convolutional Fusion for Breast Mass Segmentation in Mammographic Regions of Interest

cs.CV cs.AIcs.LG ·2026-08-15 ·Alibek Kamiluly, Milana Muratova, Yash Patel, Fan Li
similarity 0.66
Abstract

Breast mass segmentation is an important step in computer-aided mammography, but it remains difficult because masses can have low contrast, irregular shapes, and boundaries that blend with surrounding breast tissue. To address this problem, we present DualMiT-Net, a dual-branch network that uses both a focused view of the mass and a wider view of the surrounding tissue. The local branch uses a Mix Transformer (MiT-B5) encoder to learn mass shape, texture, and boundary information, while the global branch uses an EfficientNet-B5 encoder to learn surrounding breast context. Features from the two branches are shared at the deeper encoder levels and are then progressively fused in a single decoder. A spatial gate controls how much global information is added during decoding. We also evaluated four input representations and selected a percentile-windowed mammogram combined with a Gabor texture response. The model was trained and evaluated on the mass subset of the Curated Breast Imaging Subset of the Digital Database for Screening Mammography (CBIS-DDSM) using a patient-level split. Across three training runs, DualMiT-Net with exponential moving average weights achieved a mean Dice coefficient of 0.9375 and a mean Intersection over Union of 0.8834. It also achieved better Dice and IoU scores than six standard encoder-decoder baselines trained using the same data and training settings. These results show that combining local mass information with wider breast context can provide accurate and consistent breast mass segmentation.

0.04

Deep Learning-Based Prediction of HER2 Status from Whole-Brain MRI in Breast Cancer Brain Metastases

cs.LG ·2026-10-23 ·Sara Early, Chris Kang, Vibujithan Vigneshwaran, Kimberly Amador, Roger Y. Tsang +1 more
similarity 0.66
Abstract

Purpose: Human epidermal growth factor receptor 2 (HER2) status is a key biomarker relevant for prognostication and treatment decision making in metastatic breast cancer. Thus, the aim of this work was to explore whether HER2 status can be predicted directly from whole-brain post-contrast T1-weighted (T1w) MRI scans in breast cancer brain metastases (BCBM) using deep learning, and whether providing explicit tumour segmentation information improves prediction. Methods: Using the publicly available BCBM-Radiogenomics dataset, we analysed 135 patients, including 70 HER2+ and 65 HER2- patients. Three approaches were implemented and evaluated: a conventional radiomics model, a simple fully convolutional network (SFCN) using T1w MRI scans alone, and an SFCN using T1w MRI scans with an expert-derived tumour mask as an additional input channel. Results: The radiomics model achieved an area under the receiver operating characteristic curve (ROC-AUC) of 0.602 (95% confidence interval [CI]: 0.528--0.677) while the SFCN achieved a ROC-AUC of 0.667 (95% CI, 0.63--0.71) using T1w MRI scans alone, which increased to 0.692 (95% CI, 0.58--0.81) when an explicit tumour mask was additionally provided. Conclusion: However, the modest performance across all approaches demonstrates the difficulty of predicting HER2 status from structural MRI scans alone. The difference between the segmentation-free and mask-guided SFCN models suggests that much of the predictive signal captured by the deep-learning model may be learned directly from whole-brain T1w MRI without requiring explicit tumour delineation. These findings support further investigation of segmentation-free deep-learning approaches as a potential non-invasive strategy to support HER2 status determination in BCBM.

0.19

Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy Using Temporal Deep Learning on DWI

cs.AI ·2026-08-18 ·Pablo García Marcos, Md. Tarequl Islam, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez +3 more
similarity 0.65
Abstract

Early identification of non-responders to neoadjuvant chemotherapy (NACT) is crucial for timely treatment adaptation in breast cancer. However, many existing predictive models rely on multiparametric magnetic resonance imaging (MRI), late treatment time points, or extensive clinical data, which limits their applicability. This study proposes a deep learning framework for early prediction of pathological complete response (pCR) using only diffusion-weighted MRI (DW-MRI) acquired at baseline and after the first NACT cycle. This framework feeds cropped tumor-centered patches to an EfficientNet-based temporal model that directly learns tumor shape and local tissue characteristics without explicit radiomic feature engineering. The model, trained with 10-fold cross-validation, achieved an area under the receiver operating characteristic curve (AUC) of 0.90 for pCR prediction after one cycle, providing actionable information after a single treatment cycle while avoiding gadolinium administration and reducing dependence on heterogeneous clinical data. By focusing on the baseline-to-first-cycle window instead of later stages, the approach supports earlier escalation or de-escalation of NACT, and its exclusive reliance on DW-MRI facilitates protocol standardization, multi-centre deployment and privacy-preserving data sharing. These results demonstrate that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.

0.21

Feature Space Guidance for Breast Cancer Classification in DCE-MRI

cs.CV cs.AI ·2026-09-26 ·Benjamin Hamm, Yannick Kirchhoff, Maximilian Rokuss, Moritz Langenberg, Constantin Ulrich +4 more
top venuecode/data similarity 0.65
Abstract · 11 pages, 2 figures, 2 tables. Code: https://github.com/MIC-DKFZ/CURIAtor

Dynamic contrast enhanced breast MRI (DCE-MRI) is a powerful clinical tool for breast cancer detection, providing high resolution anatomical detail together with rich temporal contrast information. However, high dimensional 4D inputs, small lesions, and heterogeneous acquisition protocols across clinical sites hinder robust automated classification of healthy, benign, and malignant cases. To address these challenges, we propose a framework that dynamically analyzes latent representations to adapt to protocol-specific characteristics. Spatial variability is mitigated by reducing confounding background uptake and compensating for misalignment caused by deformable soft tissue. Additionally, relationships in the latent space across phases are leveraged to select the most informative temporal features, improving robustness to protocol-specific temporal variability. Finally, task specific discriminative features are promoted through large scale supervised lesion segmentation pretraining, which substantially enhances downstream finetuning. Evaluated under leave-one-center-out validation on the ODELIA dataset and the held-out AMBL cohort, the proposed framework substantially outperforms finetuned radiology foundation models and prior methods, improving mean AUROC by nearly 8 points and balanced accuracy by 4 points over the strongest baseline. Additionally, our method achieved first place in the MICCAI ODELIA Breast MRI Challenge 2025, further demonstrating its effectiveness for robust breast cancer classification. We publicly release our codebase under https://github.com/MIC-DKFZ/CURIAtor.

0.70

Anatomy-Aware Synthesis of Post-Contrast Breast MRI from Pre-Contrast Images

cs.CV ·2026-09-22 ·Zhengbo Zhou, Dooman Arefan, Lin Gu, Ufara Zuwasti Curran, Shandong Wu
similarity 0.64
Abstract

We developed an anatomy-aware deep learning framework to synthesize post-contrast breast MRI from pre-contrast images, emphasizing tumor and background parenchymal enhancement (BPE) regions. This retrospective study included 649 patients with 6,251 paired pre-contrast and post-contrast images. The framework integrates breast mask consistency, lesion-region supervision, and BPE-region supervision into an image-to-image translation model. Evaluation included quantitative image quality metrics, a reader study with two breast radiologists, and downstream Ki-67 classification. The proposed method outperformed Pix2Pix, Pix2PixHD, diffusion-based synthesis, and mask-supervised baselines in whole-image and regional evaluations. Ki-67 classification showed no statistically significant performance differences across real- and synthetic-image training and testing settings, although this does not establish equivalence. These findings suggest that anatomy-aware supervision improves synthesis fidelity and support further investigation of synthetic post-contrast MRI for contrast-free imaging workflows.

0.13

A Lightweight CNN Integrated Compact Convolutional Transformer for Multi-Scale Feature Learning and reducing computational complexity for breast cancer mammography image detection and classification

cs.LG cs.AIcs.CV ·2026-09-16 ·Md Taimur Ahad, Ainuddin Ahmed
similarity 0.64
Abstract

Over the years, Convolutional Neural Networks (CNNs) have demonstrated strong capability in cancer detection and classification using medical images. However, CNN-based models often struggle to capture long-range contextual dependencies. In such scenarios, integrating Compact Convolutional Transformer (CCT) architectures after the CCT layer allows CNN-extracted features to reshape into compact patch tokens using a CCT tokenizer, followed by the addition of positional embeddings to preserve spatial structure. Using 5-fold cross-validation, the model was tested on 3 sets of breast cancer mammography. With only 250,435 parameters, the model achieved 99%-100% accuracy across 3 datasets, indicating robust generalization. Explainable AI (XAI) was integrated into the model to explain the breast cancer classification process to enhance clinical trust. The results indicate that the proposed framework is suitable for computer-aided diagnosis systems, particularly in resource-constrained clinical environments. The novelty of the proposed CNN-integrated CCT overcomes the limitation of CNN's gradient degradation in the last layers by integrating convolutional tokenization with transformer-based learning. Lighter than ViT, which is effective in capturing long-range dependencies, the model has also proven efficient in breast cancer classification by capturing long-range dependencies among breast tissue regions.

0.20